Winslow Evans & Crocker’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Winslow Evans & Crocker’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$12K	Hold	100	–	–	﹤0.01%	924
2020 Q3	$10K	Hold	100	–	–	﹤0.01%	764
2020 Q2	$12K	Hold	100	–	–	﹤0.01%	715
2020 Q1	$10K	Hold	100	–	–	﹤0.01%	727
2019 Q4	$12K	Hold	100	–	–	﹤0.01%	801
2019 Q3	$12K	Hold	100	–	–	﹤0.01%	785
2019 Q2	$18K	Hold	100	–	–	0.01%	706
2019 Q1	$18K	Hold	100	–	–	0.01%	707
2018 Q4	$10K	Hold	100	–	–	﹤0.01%	790
2018 Q3	$18K	Hold	100	–	–	0.01%	701
2018 Q2	$14K	Hold	100	–	–	﹤0.01%	754
2018 Q1	$11.3K	Hold	100	–	–	﹤0.01%	760
2017 Q4	$13.2K	Buy	100 +90	+900%	+$10.6K	﹤0.01%	754
2017 Q3	$1.02K	Sell	10 -75	-88%	-$8.03K	﹤0.01%	1059
2017 Q2	$8.52K	Sell	85 -1	-1%	-$108	﹤0.01%	950
2017 Q1	$10.3K	Hold	86	–	–	﹤0.01%	890
2016 Q4	$9.5K	Buy	+86	New	+$10.4K	﹤0.01%	890
2016 Q3	–	Sell	-50	Closed	-$4.58K	–	1324
2016 Q2	$4.58K	Hold	50	–	–	﹤0.01%	1051
2016 Q1	$3.61K	Hold	50	–	–	﹤0.01%	1084
2015 Q4	$3.47K	Buy	+50	New	+$4.07K	﹤0.01%	1144

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Winslow Evans & Crocker's GWPH Position: Q4 2020 in Review

Winslow Evans & Crocker held its GW Pharmaceuticals Plc American Depositary Shares (GWPH) position steady in Q4 2020 at 100 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #924.

Winslow Evans & Crocker first reported a position in GWPH in Q4 2015 and has held it in 20 quarters since. The position peaked at $18K in Q2 2019. 279 funds tracked by Wall St. Rank hold GWPH as of Q4 2020.

Winslow Evans & Crocker held 100 shares of GW Pharmaceuticals Plc American Depositary Shares worth $12K as of Q4 2020.
Winslow Evans & Crocker left its GW Pharmaceuticals Plc American Depositary Shares share count unchanged in Q4 2020.
GW Pharmaceuticals Plc American Depositary Shares made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #924 holding.
Winslow Evans & Crocker first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2015 and has held it in 20 quarters since.
Winslow Evans & Crocker's GW Pharmaceuticals Plc American Depositary Shares position peaked at $18K in Q2 2019.
279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.